. . . . . "Pharmacogenomics-guided clopidogrel strategy represents a cost-effective treatment for patients undergoing PCI" . . . . . . . . . . . "Our data show that pharmacogenomics-guided clopidogrel treatment strategy may represent a cost-effective choice compared with non-pharmacogenomics-guided strategy for patients undergoing PCI." . . "Tobias Kuhn" . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQD4Wj537OijfOWVtsHMznuXKISqBhtGDQZfdO6pbb4hg9EHMcUFGTLbWaPrP783PHv8HMAAPjvEkHLaOHMIknqhaIa5236lfBO3r+ljVdYBElBcLvROmwG+ZGtmPNZf7lMhI15xf5TfoaSa84AFRd5J2EXekK6PhaFQhRm1IpSYtwIDAQAB" . "HlMAcgmJq6kR/uLncsCW0hT/lybYDkou8/SS6vDJC/0UYyAtjIUViijEGA588DtX1IHh9aU5u/6HeF2KK5XIrnmTpwxhnUghKEBtnaHNZT4nIZRpPxcQzhHD3RC+CFik/EPGZEtCDmc//+lh9A2R96qnwKOBVwW4cyGs1rR8cFw=" . . . "2025-04-09T06:24:52.162Z"^^ . . . . . . . . . . . . . . . . .